RR

Raksha Rai

Active Director Director DIN 08303223
DIN 08303223 First appointment Dec 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Raksha Rai

Data last updated:

Raksha Rai is a Director at Raksha Medipharma Private Limited (since 2018). The company operates in Trading. Raksha Medipharma Private Limited reported revenue of ₹1.3 Lakh (FY 2017).

DIN 08303223
Primary Designation Director
Industry Trading
First Appointment 14 Dec 2018
Oldest Company Age 13 yrs
Largest company Raksha Medipharma Private Limited · ₹1.3 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raksha Medipharma Private Limited U74120UP2013PTC055453
Director14 Dec 20182013₹1.3 Lakh (FY 2017)Active

Board colleagues of Raksha Rai

Directorship timeline

Open interactive timeline →
Raksha Medipharma Private Limited
Premium access

Shareholding and investment profile for Raksha Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raksha Rai

Raksha Rai currently holds 1 directorship: Raksha Medipharma Private Limited (Director, since 14 Dec 2018, revenue ₹1.3 Lakh (FY 2017)).

Raksha Rai was first appointed on 14 Dec 2018 as Director at Raksha Medipharma Private Limited.

The current boards of Raksha Rai's companies include Adarsh Rai (Raksha Medipharma Private Limited), Ragini Rai (Raksha Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available